Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

DNA sequencing technology available for licensing

Feb. 24, 1997

Transcriptional cofactor offered by NIH

Feb. 24, 1997

ARIAD and Genovo form gene therapy joint venture

Feb. 21, 1997

Inex and Schering-Plough complete research collaboration

Feb. 14, 1997

Alza/Alkermes stock purchase and development agreements

Feb. 14, 1997

Annual Report: CellPro

Feb. 14, 1997

Lilly/Taisho sign technology transfer agreement

Feb. 13, 1997

IDEC receives patent coverage for platform technology

Feb. 12, 1997

Merck & Co. and Costa Rican institute renew biological diversity agreement

Feb. 11, 1997

Genentech funds basic research related to human birth defects

Feb. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...